Thyroid Gland Organoids: Current Models and Insights for Application in Tissue Engineering.

Area of Science:

• Regenerative Medicine
• Tissue Engineering
• Endocrinology

Background:

• Increasing incidence of thyroid disease and hypothyroidism necessitates lifelong levothyroxine treatment.
• Current hormone replacement therapy often leads to reduced quality of life due to persistent symptoms.
• Need for novel therapeutic strategies beyond conventional hormone supplementation.

Purpose of the Study:

• To review current knowledge on thyroid regenerative medicine utilizing organoids for tissue engineering.
• To discuss methods for optimizing thyroid engineering culture systems.
• To identify challenges in utilizing thyroid organoid models for therapeutic applications.

Main Methods:

• Review of existing literature on thyroid-derived organoids and tissue engineering.
• Analysis of current thyroid engineering culture systems and optimization strategies.
• Discussion of challenges and future directions in the field.

Main Results:

• Thyroid-derived organoids represent a viable model for tissue engineering.
• Optimization of culture systems is crucial for developing functional engineered thyroid tissue.
• Significant challenges remain in translating organoid models to clinical hypothyroidism treatment.

Conclusions:

• Thyroid regenerative medicine using organoids holds potential for future hypothyroidism treatment.
• Further research is needed to optimize engineering systems and overcome current limitations.
• This approach may offer an alternative to lifelong hormone replacement therapy, improving patient outcomes.